Searching for physiologically relevant in vitro dissolution techniques for orally inhaled drugs S Radivojev, S Zellnitz, A Paudel, E Froehlich International journal of pharmaceutics 556, 45-56, 2019 | 58 | 2019 |
Use of PBPK Modeling To Evaluate the Performance of DissolvIt, a Biorelevant Dissolution Assay for Orally Inhaled Drug Products M Hassoun, M Malmlöf, O Scheibelhofer, A Kumar, S Bansal, E Selg, ... Molecular pharmaceutics 16 (3), 1245-1254, 2019 | 29 | 2019 |
Impact of simulated lung fluid components on the solubility of inhaled drugs and predicted in vivo performance S Radivojev, G Luschin-Ebengreuth, JT Pinto, P Laggner, A Cavecchi, ... International Journal of Pharmaceutics 606, 120893, 2021 | 27 | 2021 |
How does secondary processing affect the physicochemical properties of inhalable salbutamol sulphate particles? A temporal investigation JT Pinto, S Radivojev, S Zellnitz, E Roblegg, A Paudel International Journal of Pharmaceutics 528 (1-2), 416-428, 2017 | 20 | 2017 |
Insights into DPI sensitivity to humidity: An integrated in-vitro-in-silico risk-assessment S Radivojev, JT Pinto, E Fröhlich, A Paudel Journal of Drug Delivery Science and Technology 52, 803-817, 2019 | 9 | 2019 |
Elucidation of the effect of added fines on the performance of dry powder inhalation formulations M Stankovic-Brandl, S Radivojev, P Sailer, FK Penz, A Paudel International Journal of Pharmaceutics 629, 122359, 2022 | 3 | 2022 |
Integration of mucus and its impact within in vitro setups for inhaled drugs and formulations: Identifying the limits of simple vs. complex methodologies when studying drug … S Radivojev, L Kargl, JT Pinto, M Swedrowska, M Malmlöf, C Meindl, ... International Journal of Pharmaceutics 661, 124455, 2024 | | 2024 |
The Use of Integrated in-Vitro-in-Silico frameworks Toward De-Risking Low-Dose Dry Powder Inhalation Development J Pinto, S Radivojev, V Reinisch, E Fröhlich, A Paudel 2022 AIChE Annual Meeting, 2022 | | 2022 |
Investigation on the impact of resonant acoustic mixing parameters and carrier type on the deposition patterns of Budesonide/Formoterol Fumarate DPI combination product S Radivojev, M Beretta, V Reinisch, JT Pinto, E Fronich, A Paudel JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 35 (2), A14-A15, 2022 | | 2022 |
THE RELEVANCE OF SIMULATED LUNG FLUID COMPOSITION ON THE DRUG SOLUBILITY AND PREDICTED IN-VIVO PERFORMANCE OF INHALED DRUG DELIVERY S Radivojev, G Luschin-Ebengreuth, JT Pinto, A Paudel, E Froehlich JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 34 (3), A11-A11, 2021 | | 2021 |
Structural investigation into the physical interactions of itraconazole with DPPC S Radivojev, JT Pinto, P Laggner, E Froehlich, A Paudel JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 33 (2), A6-A7, 2020 | | 2020 |
Insights into humidity-induced changes on the in-vitro pulmonary deposition and the predicted plasma levels of budesonide from commercial DPIs: a pharmacokinetic model assisted … S Radivojev, JT Pinto, E Froehlich, A Paudel JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 32 (2), A4-A4, 2019 | | 2019 |
INSIGHTS INTO DPI SENSITIVITY TO HUMIDITY AND ITS CORRELATION TO FORMULATION PHYSICOCHEMICAL CHARACTERISTICS: A TEMPORAL STUDY USING TWO COMMERCIAL BUDESONIDE PRODUCTS JT Pinto, S Radivojev, E Froehlich, A Paudel JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 32 (2), A2-A2, 2019 | | 2019 |
The influence of mucus on the permeability of inhalable APIs S Radivojev, L Kargl, C Meindl, JT Pinto, A Paudel, E Fröhlich Session A: Analytics I, 0 | | |